Genmab's total assets for Q3 2024 were kr39.66B, an increase of 2.70% from the previous quarter. GMAB total liabilities were kr7.74B for the fiscal quarter, a 1.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.